Several companies have received funding that will create more Fort Lauderdale jobs. Visit http://broward.jobing.com to learn more.
BioFlorida recently announced that 77 companies throughout the state have received a total of $22.6 million in grants and tax credits through the Qualifying Therapeutic Discovery Project Program, which was created under the Patient Protection and Affordable Care Act.
The Qualifying Therapeutic Discovery Project Program is aimed at promoting research and development of products and therapies that can significantly advance the healthcare industry throughout America.
"This is a great way to help young innovative companies through these tough economic times, and we will continue to support efforts to expand and extend the therapeutic tax credit program in Congress," Russell Allen, president and CEO of BioFlorida said. "We continue to advocate for state-sponsored support for emerging bioscience companies to continue the momentum of the federal program, and to help create the high value jobs in our industry that will strengthen Florida’s economy."
The U.S. Department of the Treasury received more than 5,600 applications requesting more than $10 billion in funding. About 43 companies in Broward, Miami-Dade, and Palm Beach counties were among those to receive funding. Each company was awarded up to $244,479.25 in funding per application.
Companies in Fort Lauderdale that received funding include:
- Concordia Pharmaceuticals - $244,479.24
- LifeSync Corp., Ft. Lauderdale - $244,479.25
- Orbus Neich Medical, Ft. Lauderdale - $244,479.24
- Precision Medical Devices, Ft. Lauderdale - $244,479.25